Anagrelide
NDC 70954-881, Anagrelide, capsule, from ANI Pharmaceuticals, Inc..
- Product NDC
- 70954-881
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076811
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70954-881 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ANAGRELIDE HYDROCHLORIDE1 mg/1
Pharmacologic classes
Decreased Platelet Production [PE]; Phosphodiesterase 3 Inhibitors [MoA]; Platelet-reducing Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70954-881-10 | 70954088110 | 100 CAPSULE in 1 BOTTLE (70954-881-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/56b3959d-4b6b-413f-b753-9d4c20c07466NADAC price for package 70954088110
GET /v1/drugs/nadac/70954088110
Use it
Look up 70954-881 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70954-881 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70954-881. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.